BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18607142)

  • 1. Secondary hypertension: obesity and the metabolic syndrome.
    Singer GM; Setaro JF
    J Clin Hypertens (Greenwich); 2008 Jul; 10(7):567-74. PubMed ID: 18607142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension in obese patients: Pathophysiology and management].
    Girerd X; Hansel B
    Presse Med; 2009 Apr; 38(4):609-13. PubMed ID: 19233604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
    Kalil GZ; Haynes WG
    Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.
    Owen JG; Reisin E
    Curr Hypertens Rep; 2015 Jun; 17(6):558. PubMed ID: 25916862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of arterial hypertension in obese patients.
    Wenzel UO; Benndorf R; Lange S
    Semin Nephrol; 2013 Jan; 33(1):66-74. PubMed ID: 23374895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hypertension in obesity].
    Scholze J; Sharma AM
    Herz; 2001 May; 26(3):209-21. PubMed ID: 11413801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and treatment of obesity hypertension.
    Wofford MR; Hall JE
    Curr Pharm Des; 2004; 10(29):3621-37. PubMed ID: 15579059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Aldosterone in Obesity-Related Hypertension.
    Kawarazaki W; Fujita T
    Am J Hypertens; 2016 Apr; 29(4):415-23. PubMed ID: 26927805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin and hypertension in obesity.
    Bravo PE; Morse S; Borne DM; Aguilar EA; Reisin E
    Vasc Health Risk Manag; 2006; 2(2):163-9. PubMed ID: 17319461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.
    Reisin E; Jack AV
    Med Clin North Am; 2009 May; 93(3):733-51. PubMed ID: 19427502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension and obesity.
    Aneja A; El-Atat F; McFarlane SI; Sowers JR
    Recent Prog Horm Res; 2004; 59():169-205. PubMed ID: 14749502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension and overweight].
    Slany J
    Wien Med Wochenschr; 2008; 158(13-14):370-2. PubMed ID: 18677587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence the risk of hypertension in obese individuals.
    Coatmellec-Taglioni G; Ribière C
    Curr Opin Nephrol Hypertens; 2003 May; 12(3):305-8. PubMed ID: 12698070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension and obesity: epidemiology, mechanisms and clinical approach.
    Becton LJ; Shatat IF; Flynn JT
    Indian J Pediatr; 2012 Aug; 79(8):1056-61. PubMed ID: 22664863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of leptin-mediated sympatho-activation on cardiovascular function in obese mice.
    Belin de Chantemèle EJ; Mintz JD; Rainey WE; Stepp DW
    Hypertension; 2011 Aug; 58(2):271-9. PubMed ID: 21690486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension.
    Engeli S; Sharma AM
    Curr Opin Cardiol; 2002 Jul; 17(4):355-9. PubMed ID: 12151869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hypertension in obese patients].
    Comte-Perret S; Giusti V; Wuerzner G
    Rev Med Suisse; 2013 Sep; 9(397):1622, 1624-6. PubMed ID: 24073473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
    da Silva AA; do Carmo JM; Li X; Wang Z; Mouton AJ; Hall JE
    Can J Cardiol; 2020 May; 36(5):671-682. PubMed ID: 32389340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.